lost 5 pounds first week of semaglutide Wegovy Before and After: Real People, Real Results Only One Week on Semaglutide

And some research has raised, if not red flags, perhaps a few yellowish ones

314, Oct

Category 1 Bulk substance the FDA considers eligible for use in compounding pending final rulemaking Generally permitted Category 2 Bulk substance the FDA has significant safety, identity, or quality concerns about Not permitted during review Category 3 Substance requiring further evaluation Case-by-case Critically, Category 1 status is not FDA approval

Still outstanding: TRIUMPH-5 (head-to-head vs tirzepatide) TRIUMPH-6 (weight maintenance) and the MASH / MASLD readouts TRIUMPH-Outcomes (cardiovascular and kidney outcomes) -- a multi-year, event-driven trial Lilly said it plans to submit a Biologics License Application (BLA) for retatrutide to the FDA in the first quarter of 2027 , based on the core TRIUMPH results and supporting filings for obesity, obstructive sleep apnea, and knee osteoarthritis